Redd&Whyte Appoints New UK Sales Manager
News Feb 21, 2013
Redd&Whyte today announced that it is strengthening its UK presence with the appointment of Sarah Chaudhry as its new UK sales manager. Sarah comes with specialist knowledge of life science laboratory equipment, making her well placed to support Redd&Whyte’s high quality range of Preddator low-volume microplate dispensers throughout the UK.
Sarah has over 12 years’ experience in sales management within major life science equipment companies including Elga Process Water and Sartorius where she supported a range of laboratory systems. Sarah’s commercial expertise is underpinned by a degree in Biomedical Sciences from Sheffield Hallam University. This provides Sarah with extensive knowledge of life science research and automated laboratory equipment to draw from, which she will use to offer advice and support on Redd&Whyte’s Preddator low-volume dispensers range.
Sarah Chaudhry, Redd&Whyte’s UK Sales Manager commented: “I am very pleased to be working for such an innovative UK company and the four channel Preddator system is a very exciting new development. I am looking forward to meeting scientists and showing them how Preddator’s unique dispense head design will help them to accurately and continuously dispense low-volumes and to explaining how it will benefit them by generating consistent assay results, while making substantial savings on reagents and operating costs.”
Roger Poole, Managing Director of Redd&Whyte continued: “We want to develop our UK presence with the Preddator so are delighted to facilitate this by adding a new UK sales manager to our team. Sarah’s specialist approach to supporting laboratory equipment, we believe will allow us to enhance our reputation for delivering unrivalled low-volume dispensing performance to all our existing and potential UK clients.”
Children With Congenital Zika Virus Infection Face Serious Challenges as They AgeNews
The report from the CDC is the first to describe the health and developmental effects of congenital Zika virus infection in children with microcephaly through 2 years of age.READ MORE
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.READ MORE